Edition:
India

China Regenerative Medicine International Ltd (8158.HK)

8158.HK on Hong Kong Stock

0.18HKD
15 Dec 2017
Change (% chg)

HK$0.00 (+1.73%)
Prev Close
HK$0.17
Open
HK$0.17
Day's High
HK$0.18
Day's Low
HK$0.17
Volume
22,500,000
Avg. Vol
37,966,331
52-wk High
HK$0.31
52-wk Low
HK$0.16

Latest Key Developments (Source: Significant Developments)

China Regenerative Medicine International To By ‍Lung Hang Investments For HK$3.6 Bln-HK$$3.8 Bln​
Monday, 11 Dec 2017 

Dec 11 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::CO TO BY ‍LUNG HANG INVESTMENTS FROM SACRED HEART HEALTHCARE LTD PARTNERSHIP FOR HK$3.6 BILLION TO HK$3.8 BILLION​.  Full Article

China Regenerative Medicine International Says Qtrly Revenue Hk$89 Million
Friday, 8 Dec 2017 

Dec 8 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::QTRLY REVENUE HK$89 MILLION VERSUS HK$25.5 MILLION ‍​.QTRLY NET LOSS HK$63.3 MILLION VERSUS NET LOSS OF HK$61.8 MLN‍​.  Full Article

China Regenerative Medicine International Says ‍Wong Sai Hung Resigned As Vice-Chairman
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::WONG SAI HUNG RESIGNED AS EXECUTIVE DIRECTOR AND VICE-CHAIRMAN OF BOARD​.  Full Article

China Regenerative Medicine International says unit to sell Shaanxi Aimiya​ to third party
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::Unit entered into deal to sell 100 percent stake in Shaanxi Aimiya​ to third party buyer.Estimated gain on disposal of about RMB28.6 million to be recorded in group's FY ending Dec. 31, 2017​.Unit to also sell loan to third party purchaser; consideration for SPA and loan RMB40 million​.  Full Article

China Regenerative Medicine International says Cui Zhanfeng will be appointed as Chairman
Wednesday, 28 Sep 2016 

China Regenerative Medicine International Ltd <8158.HK>: Cui zhanfeng will be appointed as chairman and non-executive director of company .Wong sai hung will be re-designated from chairman to vice-chairman.  Full Article

China Regenerative Medicine International enters into a collaboration agreement
Friday, 23 Sep 2016 

China Regenerative Medicine International Ltd <8158.HK> : Entered into a collaboration agreement with University Of Hong Kong ("HKU") and Innovation And Technology Commission of HKSAR . Estimated cost of project is approximately hk$8.8 million . Pursuant to collaboration agreement, co shall hold all intellectual property rights arouse from project in its sole name Source (http://bit.ly/2cqmyUV) Further company coverage: [8158.HK] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

China Regenerative Medicine International enters MOU regarding proposed sale and purchase of cell and stem cell business<8158.HK>
Wednesday, 17 Aug 2016 

China Regenerative Medicine International Ltd <8158.HK>: Crmi-joint announcement for the memorandum of understanding in relation to the proposed sale and purchase of cell and stem cell business <8158.HK> . Says HKLST and CRMI entered into a Memorandum Of Understanding . MOU in relation to proposed sale of certain companies engaged in cell and stem cell business held by CRMI group to HKLST .  Full Article

China Regenerative Medicine unit enters into loan agreement<8158.HK>
Tuesday, 26 Jul 2016 

China Regenerative Medicine International Ltd <8158.HK>: Discloseable transaction provision of the loan to an independent third party . Unit entered into a loan agreement with the borrower . Deal for HK$50 million . Borrower an independent third party incorporated in the British Virgin Islands .  Full Article

No consensus analysis data available.